Beryl Drugs Ltd - BERYL DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE415H01017

Beryl Drugs Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 4/19/2024 12:00:00 AM

    ₹ 34.33 -1.00 -2.83
  • Open
  • ₹ 35.33
  • Prev. Close
  • ₹ 35.33
  • Turnover(Lac.)
  • ₹ 0
  • Day's High
  • ₹ 35.33
  • Day's Low
  • ₹ 33.7
  • 52 Week's High
  • ₹ 44.98
  • 52 Week's Low
  • ₹ 12.1
  • Book Value
  • ₹ 17.734
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 17.41
  • P/E
  • 14.8
  • EPS
  • 2.32
  • Divi. Yield
  • 0

Beryl Drugs Ltd Corporate Actions

12 Apr , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2024

12:00 AM

31 Oct , 2023

12:00 AM

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Aug , 2023

12:00 AM

AGM

Announcement date: 25 Aug , 2023

View Details

17 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Aug , 2023

12:00 AM

18 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

25 Aug , 2023

12:00 AM

BookCloser

View Details

No Record Found


Beryl Drugs Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Beryl Drugs Ltd SHAREHOLDING SNAPSHOT
20 April , 2024 | 06:40 AM

PROMOTER - TOTAL26.38%

Indian: 26.38%

Foreign: 0%

NON-PROMOTER - TOTAL 73.62%

Institutions: 0.00%

Non-Institutions: 73.62%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Beryl Drugs Ltd FINANCIALS

No Data Available To Display Chart

Beryl Drugs Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Beryl Drugs Ltd

  • Sanjay Sethi
  • ED / MD / Promoter
  • Sudhir Sethi
  • Chairman & Non Executive Dir.
  • Abhinav Naik
  • Independent Non Exe. Director
  • Shreya Saraf
  • Independent Non Exe. Director
Company FAQ

No Record Found